RAD - Rite Aid Corporation
After hours:
Chart Events
Two Bar Reversal (Bullish)
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 1.7900 |
| Open | 1.7900 |
| Bid | 0.0000 x 4000 |
| Ask | 0.0000 x 2900 |
| Day's Range | 1.7400 - 1.8300 |
| 52 Week Range | 1.6700 - 11.6100 |
| Volume | |
| Avg. Volume | 2,512,765 |
| Market Cap | 101.005M |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -13.3400 |
| Earnings Date | Jun 21, 2023 - Jun 26, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Oct 14, 1999 |
| 1y Target Est | 1.50 |
Fair Value
Related Research
Business WireElixir announces the next wave of innovation for pharmacy benefits technology platform
PHILADELPHIA, May 23, 2023--Elixir, a pharmacy benefit management company owned by Rite Aid (NYSE: RAD), has announced details of the next release of its Laker Software technology platform. The upcoming enhancements include new automated workflows, a customer service tool and modernization of the user interface.
Exec EdgeFrom Yoga Pants to Putters: LogicSource Helps Companies Slash Procurement Costs
LogicSource helps retail, CPG, restaurant and consumer companies find efficiencies and cost savings Clients include Lululemon Athletica Inc., Tractor Supply Company, Rite Aid Corp., Société BIC SA (commonly known as BiC), WellSpan Health, Acushnet Holdings Corp.’s Titleist Five years of profitability and 170% expected three-year revenue growth rate through 2023 Indirect expenses (marketing, packaging, IT, […]
Yahoo FinanceWhy indie pharmacies, with the help of the likes of Mark Cuban, are on the rise
Independent pharmacies and startups such as Cigna's Express Scripts and Mark Cuban's Cost Plus Drugs are partnering up to address a coverage gap for some Americans.
Insider MonkeyRite Aid Corporation (NYSE:RAD) Q4 2023 Earnings Call Transcript
Rite Aid Corporation (NYSE:RAD) Q4 2023 Earnings Call Transcript April 20, 2023 Rite Aid Corporation misses on earnings expectations. Reported EPS is $-1.24 EPS, expectations were $-0.77. Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I’d like to welcome everyone to the Rite Aid Corporation […]
- Thomson Reuters StreetEvents
Q1 2023 Retail Opportunity Investments Corp Earnings Call
Q1 2023 Retail Opportunity Investments Corp Earnings Call
Business WireRite Aid Looks to ‘Ease the Sneeze’ This Allergy Season
PHILADELPHIA, April 26, 2023--It’s no secret seasonal allergies are here. From runny noses and itchy eyes to tissues carried in all pockets and bags, spring has sprung and mother nature has brought the dreaded sneeze with her. To help its suffering shoppers, Rite Aid has spent the last few weeks dusting off last season’s sales data* and speaking with real allergy victims to once and for all ‘Ease the Sneeze.’
ZacksZacks Industry Outlook Highlights CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon
CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon have been highlighted in this Industry Outlook article.
Zacks3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry
Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.
ZacksRite Aid (RAD) Q4 Loss Wider Than Expected, Revenues Beat
Rite Aid's (RAD) Q4 results gain from improvements in retail pharmacy and Elixir. However, lower revenues from COVID vaccines and testing, and store closures act as headwinds.
BenzingaWhy Rite Aid Stock Is Plunging Today
Rite Aid Corp (NYSE: RAD) has reported Q4 FY23 sales of $6.09 billion, compared to $6.06 billion a year ago, beating the consensus of $5.67 billion. The marginal change was primarily due to an extra week in the fourth quarter and increases in comparable front-end sales and non-COVID prescriptions, partially offset by a reduction in revenue from COVID vaccines and testing, store closures, and the loss of commercial clients at Elixir. The company reported an Adjusted EPS loss of $(1.24) compared t
ZacksRite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates
Rite Aid (RAD) delivered earnings and revenue surprises of -61.04% and 6.90%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
The Wall Street JournalRite Aid Seeks Direction as Pressure Mounts
Cash-strapped drugstore chain, which is looking for a permanent leader, posts larger-than-expected fourth-quarter loss.
Business WireRite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook
PHILADELPHIA, April 20, 2023--Rite Aid Corporation (NYSE: RAD) today reported operating results for its fourteen-week fourth quarter and fifty-three-week fiscal year ended March 4, 2023.
ZacksFactors Likely to Influence Rite Aid (RAD) in Q4 Earnings
Higher non-COVID prescriptions, strength in PBM and delivery service expansion are likely to have impacted Rite Aid's (RAD) Q4 performance amid sluggishness in Retail Pharmacy and Pharmacy Services.
Motley FoolBest Pharmacy Stock to Buy Right Now
All three major pharmacy chains, CVS Health (NYSE: CVS), Walgreens Boots Alliance (NASDAQ: WBA), and Rite Aid (NYSE: RAD), have seen their shares drop over the past 12 months and so far this year. In its guidance, the company said it expects 2023 EPS of $7.73 to $7.93.
ZacksWalgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
Walgreens (WBA) delivered earnings and revenue surprises of 5.45% and 4.16%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireRite Aid to Release Fourth Quarter Results on April 20
PHILADELPHIA, March 23, 2023--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2023 Fourth Quarter, which ended March 4, 2023, on Thursday, April 20, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.
The Wall Street JournalDOJ Sues Rite Aid for Allegedly Filling Opioid Prescriptions With ‘Obvious Red Flags’
The complaint alleges that hundreds of thousands of unlawful prescriptions were filled between 2014 and 2019.
BenzingaDepartment of Justice Accuses Rite Aid For Ignoring Obvious Signs Of Opioid Misuse
The U.S. government reportedly sued Rite Aid Corp (NYSE: RAD), saying the company missed "red flags" as it illegally filled prescriptions for controlled substances, including opioids. The Justice Department joined a whistleblower lawsuit filed in 2019 by two pharmacists and a pharmacy technician from Rite Aid stores in Pennsylvania, North Carolina, and West Virginia. The Justice Department accused Rite Aid of violating the federal False Claims Act by submitting false prescription claims to gover
MarketWatchU.S. alleges Rite Aid filled ‘hundreds of thousands’ of unlawful prescriptions and ‘opened the floodgates’ for illegal opioid market
Rite Aid fueled the nation's opioid crisis by knowingly filling hundreds of thousands of illegal prescriptions, the U.S. alleged in a complaint.
- Reuters
UPDATE 3-US sues Rite Aid for missing opioid red flags
The U.S. government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids. In a complaint filed in Cleveland federal court, the Department of Justice said Rite Aid repeatedly filled prescriptions from May 2014 to June 2019 that were medically unnecessary, for off-label use, or not issued in the usual course of professional practice. "The Justice Department is using every tool at our disposal to confront the opioid epidemic that is killing Americans and shattering communities across the country," Attorney General Merrick Garland said in a statement.
ReutersUS sues Rite Aid for missing opioid red flags
The U.S. government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids. In a complaint filed in Cleveland federal court, the Department of Justice said Rite Aid repeatedly filled prescriptions from May 2014 to June 2019 that were medically unnecessary, for off-label use, or not issued in the usual course of professional practice. "The Justice Department is using every tool at our disposal to confront the opioid epidemic that is killing Americans and shattering communities across the country," Attorney General Merrick Garland said in a statement.
- Reuters
UPDATE 1-New York officials ask 3 pharmacy chains for plans on abortion drug access
New York government officials on Thursday sent a letter to pharmacy operators CVS Health Corp , Walgreens Boot Alliance and Rite Aid Corp , asking about their plans to make abortion pill mifepristone available in the state. The letter from New York Governor Kathy Hochul and Attorney General Letitia James asked the companies to respond in writing within 10 business days about their commitment to dispense mifepristone at U.S. drug regulator-certified pharmacy locations and via mail in the state.
- Reuters
New York officials ask 3 pharmacy chains for plans on abortion drug access
New York government officials on Thursday sent a letter to pharmacy operators CVS Health Corp , Walgreens Boot Alliance and Rite Aid Corp , asking about their plans to make abortion pill mifepristone available in the state. The letter from New York Governor Kathy Hochul and Attorney General Letitia James asked the companies to respond in writing within 10 business days about their commitment to dispense mifepristone at U.S. drug regulator-certified pharmacy locations and via mail in the state. Walgreens, Rite Aid and CVS did not immediately respond to Reuters' requests for comment.